GEVOGevo, Inc.
Industrial Organic Chemicals
- Revenue
- $161M
- 849% YoY
- Operating margin
- -12.6%
- 98% YoY
- EBITDA
- −$7M
- 90% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- $109M net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCClear6% of revenueOver 10% of revenue
- Payouts exceed cash flowClear-35% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear9% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $533K | $1M | $17M | $17M | $161M | 849% |
| Operating income | −$60M | −$103M | −$82M | −$91M | −$20M | 78% |
| Net income | −$59M | −$98M | −$66M | −$79M | −$34M | 57% |
| Operating cash flow | −$48M | −$44M | −$54M | −$57M | −$13M | 77% |
| Capex | $57M | $84M | $54M | $51M | $30M | 41% |
| Stock-based comp | $10M | $17M | $17M | $15M | $9M | 37% |
| Buybacks | — | — | — | $5M | — |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $23K · 4
- Net
- −$23K
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | $3M | $3M | 47 | — |
| FY2024 | $3M | $6M | 49 | — |
| FY2023 | $4M | $2M | 27 | — |
| FY2022 | $3M | −$3M | 45 | — |
| FY2021 | $11M | $12M | 101 | — |